Det primære effektmål i begge forsøg var andelen af patienter, der opnåede PASI 75- respons i forhold til baseline i uge 12 (se tabel 2).
The primary endpoint in both studies was the proportion of patients who achieved PASI 75 response from baseline at Week 12 (see Table 2).